Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn’s Disease

Introduction: A large proportion of small bowel lesions in Crohn’s disease (CD) may exist beyond the reach of ileocolonoscopy and there is no gold standard imaging modality to screen them, suggesting the need for optimal biomarkers. We aimed to compare the usefulness of C-reactive protein (CRP), fae...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kunio Asonuma, Taku Kobayashi, Nao Kikkawa, Masaru Nakano, Shintaro Sagami, Hiromu Morikubo, Yusuke Miyatani, Aya Hojo, Tomohiro Fukuda, Toshifumi Hibi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Karger Publishers 2023-05-01
coleção:	Inflammatory Intestinal Diseases
Assuntos:	crohn’s disease endoscopic healing biomarker leucine-rich alpha-2 glycoprotein
Acesso em linha:	https://beta.karger.com/Article/FullText/530825
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!